Clinical trial
Phase 2b Clinical Trial Using Multiple Interventions With Distinct Anti-Reservoir Activities In People On Antiretroviral Treatment
NCT07903441 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2b Clinical Trial Using Multiple Interventions With Distinct Anti-Reservoir Activities In People On Antiretroviral Treatment
- Lead sponsor
- Federal University of São Paulo
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv - human immunodeficiency virus
Arms
As registered; 2 arms.
-
Control
-
Multiple therapeutic interventions
Primary endpoints
Registered primary outcome measures; 6 primary.
-
Evolution of viral load of HIV RNA over the time frame of the study by ultrasensitive RT-qPCR
-
Evolution of cell-associated HIV RNA in PBMCs by qPCR. over the study time frame
-
Evolution of total DNA and episomal HIV DNA in lymphoid tissue (rectal biopsy)
Quantification by in-house virological assay
-
Evolution of percentages of CD38 and HLA DR in CD4 + and CD8 + T lymphocytes
Measurement by flow cytometry of cell activation of CD4+ and CD8+ T lymphocytes as a means of assessing immune and inflammatory responses
-
Evolution of the HIV RNA sequence of the V3 region of gp 120, protease, reverse transcriptase and integrase regions of the pol gene, and of the gag gene
NGS sequencing of the V3 region of gp120, the protease, reverse transcriptase, and integrase regions of the pol gene, and of the gag gene of HIV RNA
+1 more primary endpoint
Lead sponsor's other trials
Federal University of São Paulo, most recent start first.
+433 more trials
Similar trials
Same condition (Acquired Immunodeficiency Syndrome) and phase, most recent start first.
+316 more trials See the condition page